Summary

The global CRISPR Gene Editing Market is expected to grow at a significant rate of around 5% during the forecast period. CRISPR gene editing is a scientific method that enables geneticists and medical researchers to modify, add, or delete specific DNA sequences to alter portions of the genome. It is currently the most straightforward, adaptable, and precise method of genetic modification. CRISPR has a lot of potential as a tool for treating genetic diseases like cancer, high cholesterol, and hepatitis B. For instance, according to the World Health Organization, around 296 million people were living with chronic hepatitis B infection in 2019, with 1.5 million new infections occurring every year.

The CRISPR gene editing market is a rapidly growing and highly competitive market, driven by the increasing demand for new and effective treatments for various diseases and conditions, as well as the growing interest in precision medicine and personalized treatments. With advancements in technology and the increasing number of companies entering the market, the market is expected to continue growing in the coming years. For instance, in 2020, zon Discovery Group launched the Edit-R CRISPRa Portfolio. The Edit-R CRISPRa Portfolio is a collection of plasmids that use CRISPR activation (CRISPRa) technology to turn on the expression of specific genes in mammalian cells. The Edit-R CRISPRa Portfolio provides researchers with a powerful tool for studying gene function and developing new therapies for genetic diseases.

CRISPR Therapeutics; Thermo Fisher Scientific Inc.; Synthego; System Biosciences, LLC; ToolGen, Inc.; Agilent Technologies, Inc.; Merck KGaA; Applied StemCell; GeneCopoeia, Inc.; Cellecta, Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report
“Amongst applications, the agricultural category is anticipated to register the fastest growth rate during the forecast period.”
On the basis of application, the market is categorized into agricultural, biomedical (gene therapy, drug discovery, and diagnostics), industrial, and others. Among these, the agricultural category is anticipated to register the fastest growth rate during the forecast period. This is mainly due to the consumption of nutritional food has risen globally because of improvements in agricultural productivity brought on by the adoption of advanced breeding technologies. For instance, researchers at Cold Spring Harbor Laboratory used CRISPR/Cas9 technology in June 2019 to create mutations in the tomato flowering suppressor, which led to quick flowering, more compact development, and ultimately an early harvest.

“Amongst end-user, academic institutes and research centers category to witness fastest CAGR during the forecast period.”
Based on end-user, the market is segmented into academic institutes & research centers, biotechnology companies, contract research organizations (CROs), and pharmaceutical & biopharmaceutical companies. The academic institutes and research centers category witness the fastest CAGR during the forecast period owing to their fundamental research, innovation, training & education, and collaborations with industry partners. These activities are crucial for the continued growth and success of the CRISPR gene editing market.

“APAC is anticipated to witness the fastest growth of the market”
For a better understanding of the market adoption of the CRISPR gene editing industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to witness the fastest growth in the market. This is mainly due to the increasing investments in gene editing research, the rising prevalence of genetic disorders, and the adoption of CRISPR technology in agriculture & animal breeding in the region. Also, the increasing government investment in R&D and patents assigned for these technologies to develop novel treatments is driving market expansion in developing countries. For instance, in March 2021, a CRISPR-Cas9 patent was given to the Japanese biotech firm Setsuro Tech by the Dublin-based ERS Genomics. With the help of these advanced technologies, the company is developing cell & animal models.

Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:
The global CRISPR gene editing market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

ページTOPに戻る

Table of Contents